Urokinase- Dukinase 025 Million Iu Samarth Pharma

Information About Urokinase- Dukinase 025 Million Iu Samarth Pharma

About Urokinase- Dukinase 025 Million Iu Samarth Pharma

The Medicine Brand Dukinase 025 million iu Samarth Pharma is manufactured by Samarth Life Sciences Pvt Ltd and mainly contents the generic drug Urokinase.

Pakaging

1 Vial

Active Ingredients For Urokinase- Dukinase 025 Million Iu Samarth Pharma

Urokinase 025 million iu

Diseases List For Which Urokinase- Dukinase 025 Million Iu Samarth Pharma Is Prescribed

This Drug Is Prescribed For Acute myocardial infarction Deep vein thrombosis Pulmonary embolism Peripheral vascular thromboembolism

Other Significations For Urokinase- Dukinase 025 Million Iu Samarth Pharma

This Medication This medication is a protein enzyme which works to break up and dissolve blood clots which can block arteries It is used in the treatment of very serious blood clots in lung blood vessels pulmonary embolism

Precautions To Be Taken Before Urokinase- Dukinase 025 Million Iu Samarth Pharma

Tell your doctor of any prescription or nonprescription medication you may take including blood thinners eg warfarin NSAIDs eg ibuprofen naproxen aspirin Drugs that can reverse effects of urokinase include aminocaproic acid aprotinin tranexamic acid Aspirin or NSAID drugs eg ibuprofen should not be used to treat fever since they may increase the chance of bleeding while using urokinase Do not start or stop any medicine without doctor or pharmacist approval

Major Conditions And Care

Pregnancy And Urokinase- Dukinase 025 Million Iu Samarth Pharma

Can We Take Urokinase- Dukinase 025 Million Iu Samarth Pharma During Pregnancy?

Pregnancy Class C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation And Urokinase- Dukinase 025 Million Iu Samarth Pharma

Can We Use Urokinase- Dukinase 025 Million Iu Samarth Pharma During Lactation

Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective

Side Effects Of Urokinase- Dukinase 025 Million Iu Samarth Pharma

Nausea stomach upset skin rash acute toxicity

More Danger Effects Fatal Effect Due To Overdose Of Urokinase- Dukinase 025 Million Iu Samarth Pharma